666

FENG CHI BIOTECH CORP

No trades
See on Supercharts
Market capitalization
‪337.87 M‬TWD
‪22.79 M‬TWD
‪180.58 M‬TWD
Beta (1Y)
0.10

About FENG CHI BIOTECH CORP

CEO
Hung Ming Chang
Headquarters
Taipei
Founded
1992
ISIN
TW0006744006
FIGI
BBG00Q9DQDD3
Feng Chi Biotech Corp. provides prenatal testing, new born screening, life science and microbiological testing services. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6744 is 23.00 TWD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange FENG CHI BIOTECH CORP stocks are traded under the ticker 6744.
6744 stock is 0% volatile and has beta coefficient of 0.10. Check out the list of the most volatile stocks — is FENG CHI BIOTECH CORP there?
Yes, you can track FENG CHI BIOTECH CORP financials in yearly and quarterly reports right on TradingView.
6744 stock has fallen by 0.22% compared to the previous week, the month change is a 2.22% rise, over the last year FENG CHI BIOTECH CORP has showed a 19.72% decrease.
6744 net income for the last quarter is ‪9.49 M‬ TWD, while the quarter before that showed ‪13.30 M‬ TWD of net income which accounts for −28.68% change. Track more FENG CHI BIOTECH CORP financial stats to get the full picture.
Today FENG CHI BIOTECH CORP has the market capitalization of ‪337.87 M‬, it has decreased by 0.22% over the last week.
Yes, 6744 dividends are paid annually. The last dividend per share was 1.35 TWD. As of today, Dividend Yield (TTM)% is 5.87%. Tracking FENG CHI BIOTECH CORP dividends might help you take more informed decisions.
FENG CHI BIOTECH CORP dividend yield was 4.73% in 2023, and payout ratio reached 70.95%. The year before the numbers were 6.75% and 84.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6744 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FENG CHI BIOTECH CORP stock right from TradingView charts — choose your broker and connect to your account.
6744 reached its all-time high on May 25, 2020 with the price of 71.00 TWD, and its all-time low was 18.00 TWD and was reached on Nov 11, 2022.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FENG CHI BIOTECH CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FENG CHI BIOTECH CORP stock shows the sell signal. See more of FENG CHI BIOTECH CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FENG CHI BIOTECH CORP EBITDA is ‪31.38 M‬ TWD, and current EBITDA margin is 17.38%. See more stats in FENG CHI BIOTECH CORP financial statements.